Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report

Presse Med. 2009 Jan;38(1):148-50. doi: 10.1016/j.lpm.2008.02.021. Epub 2008 Nov 22.

Authors

Nicolas Girard¹, Vincent Cottin, Marie-George Lapalus, François Tronc, Jean-François Cordier

Affiliation

¹ Pneumology department, Pilot Unit for Rare Thoracic Malignant Tumors, Louis Pradel Hospital, Hospices civils de Lyon, Lyon I University, Lyon, F-69677 Lyon (Bron) Cedex, France. [email protected]

PMID: 19028071
DOI: 10.1016/j.lpm.2008.02.021

No abstract available

Publication types

Case Reports

MeSH terms

Antibiotics, Antineoplastic / administration & dosage
Antineoplastic Agents / therapeutic use
Antineoplastic Agents, Alkylating / administration & dosage
Antineoplastic Agents, Phytogenic / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Benzamides
Doxorubicin / administration & dosage
Etoposide / administration & dosage
Fatal Outcome
Gastrointestinal Stromal Tumors / pathology*
Humans
Ifosfamide / administration & dosage
Imatinib Mesylate
Lung Neoplasms / pathology*
Male
Middle Aged
Neoplasms, Multiple Primary / pathology*
Palliative Care
Piperazines / therapeutic use
Pyrimidines / therapeutic use
Small Cell Lung Carcinoma / pathology*
Stomach Neoplasms / pathology*

Substances

Antibiotics, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Benzamides
Piperazines
Pyrimidines
Etoposide
Doxorubicin
Imatinib Mesylate
Ifosfamide

Supplementary concepts

AVI protocol